MARKET

ADXS

ADXS

Advaxis
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.3901
+0.0080
+2.09%
After Hours: 0.3999 +0.0098 +2.51% 19:59 11/21 EST
OPEN
0.3700
PREV CLOSE
0.3821
HIGH
0.4100
LOW
0.3565
VOLUME
6.00M
TURNOVER
--
52 WEEK HIGH
10.80
52 WEEK LOW
0.2051
MARKET CAP
9.64M
P/E (TTM)
-0.0904
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ADXS and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ADXS News

  • Advaxis Announces Business and Pipeline Update
  • Business Wire.10/24 14:00
  • Advaxis Sees Cash Balance Extending Into 2021
  • Benzinga.10/24 13:07
  • Advaxis Offers Updates For ADXS-HOT, ADXS-NEO, ADXS-PSA, ADXS-HPV Clinical Programs
  • Benzinga.10/24 13:07
  • 22 Healthcare Stocks Moving In Tuesday's Pre-Market Session
  • Benzinga.10/15 12:04

More

Industry

Biotechnology & Medical Research
-0.31%
Pharmaceuticals & Medical Research
+0.32%

Hot Stocks

Name
Price
%Change

About ADXS

Advaxis, Inc. is a clinical-stage biotechnology company focused on the discovery, development and commercialization of Listeria monocytogenes (Lm)-Listeriolysin O (LLO) cancer immunotherapies. These immunotherapies are based on a platform technology that utilizes live attenuated Lm bioengineered to secrete antigen/adjuvant fusion proteins. These Lm-LLO strains integrate multiple functions into a single immunotherapy as they access and direct antigen presenting cells to stimulate anti-tumor T-cell immunity, stimulate and activate the immune system with the equivalent of multiple adjuvants, and simultaneously reduce tumor protection in the tumor microenvironment to enable the T-cells to eliminate tumors. Axalimogene filolisbac is its lead Lm-LLO immunotherapy product candidate for the treatment of Human Papilloma Virus-associated cancers. ADXS-PSA is its Lm-LLO immunotherapy product candidate that targets the Prostate Specific Antigen (PSA) associated with prostate cancer.
More

Webull offers Advaxis, Inc. (ADXS) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.